Roberts, K. E. http://orcid.org/0000-0003-0017-0803
Beckenkamp, P. R. http://orcid.org/0000-0003-3986-6111
Ferreira, M. L. http://orcid.org/0000-0002-3479-0683
Duncan, G. E. http://orcid.org/0000-0001-6909-1869
Calais-Ferreira, L. http://orcid.org/0000-0001-6153-8080
Gatt, J. M. http://orcid.org/0000-0002-9276-6358
Ferreira, P. http://orcid.org/0000-0002-5861-7770
Funding for this research was provided by:
University of Sydney
Article History
Received: 4 June 2022
Revised: 18 August 2022
Accepted: 23 September 2022
First Online: 8 October 2022
Declarations
:
: JMG is a stockholder in MAP Biotech Pty Ltd. The authors have no other conflicts of interest to declare.
: Participants provided written informed consent using procedures approved by the Washington State University IRB (#14547).